We are currently conducting further experiments including overexpression of c-Myc in GBM cell lines to potentially overcome the effects from AR suppression, as well as CRISPR/CAS9-mediated AR knockout in GBM cell lines to investigate the multi-faceted functions of AR in GBM tumor growth. The gene discussed is MYC; the disease is neoplasm.